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Context
Need to take into account the quality of life of cancer patients
Existing
assessment tools
Quality of life Disabilities
Functional impact: 
Patient Concerns
Inventory
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Context
Carcinologic Handicap 
Index (CHI)
Aim: identify frequency
of symptoms and 
impact on everyday life
Disabilities
Functional impact
Missing topics 
reported by patients
“Limitation of neck 
and shoulder 
movements”
“Psychosocial impact 
of changes in the 
physical appearance"
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Objectives
Main objective
Validate the upgraded version 
of the questionnaire
Secondary objective
Study the link between 
the outcomes 
of the questionnaire 
and the actual expectations 
of patients in terms of care
Materials and Methods
9 dimensions from the first version of the CHI:
Sensory functions: 4
Upper aerodigestive tract functions: 4
Psychosocial impact: 1
2 new dimensions in the French version:
Items elaborated with carers and patients
Pretest phase
Subjects - Inclusion criteria: 
Patients with head and neck related
complaints
Healthy controls
Materials and Methods
7 to 15 days
CHIupgraded version
+ Visual Analog Scale
CHIupgraded version
2nd filling
Cases
Controls
Construct
validity
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Criterion
validity
Test-retest reliability
T0 T1
Materials and Methods
Analysis of priority dimensions to be supported:
Hierarchical ranking by the patient
of all the dimensions in order of importance (ICC)
Categorization of each patient’s top-3 priorities
Performance evaluation of the top-3 priority 
dimensions: 
Sensitivity, Specificity, Area Under the Curve 
Determination of the best threshold 
starting from which the dimension is in the top 3 
of the patient’s priorities
Results
71
36
Cases and controls: descriptive data
Controls
17 M, 19 F
Mean age 59.5 years
Cases
46 M, 25 F
Mean age 64.6 years
Tumor locations:
Oral cavity: 19.7%
Larynx: 21.1% 
Pharynx: 29.6%
Other location: 29.6% 
Psychometric properties of the 2 new dimensions:
Results
Limitation of neck and shoulder 
movements
Psychosocial impact of changes 
in the physical appearance
V
a
l
i
d
i
t
y
Construct validity
(convergent validity)
rSpearman: .38 – .73 rSpearman: .35 – .61
Clinical validity Mann-Whitney U test: p<.001 Mann-Whitney U test: p<.001
Criterion validity rSpearman= .68 (p<.001) rSpearman= .74 (p<.001)
R
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y Internal consistency Cronbach’s alphas > .72 Cronbach’s alphas > .75
Test-retest reliability
(response rate: 63%)
rSpearman= .80 (p<.001) rSpearman= .67 (p<.001)
Results
Determination of the top-3 threshold:
Dimensions
AUC (Area 
Under the 
Curve)
CI 95 %
Threshold
Chosen threshold Sensitivity Specificity
Correct 
classification
Pain .73 [.58 ; .87] 7 64.7% 73.6% 71.4%
Swallowing .84 [.73 ; .94] 4 93.6% 56.5% 81.4%
Feeding .78 [.67 ; .89] 7 80.8% 72.7% 75.7%
Respiration .74 [.54 ; .94] 4 87.5% 50.0% 54.3%
Phonation .85 [.74 ; .95] 6 90.9% 65.4% 81.4%
Hearing .88 [.79 ; .96] 8 83.3% 81.0% 81.4%
Vision .55 [.35 ; .75] NC NC NC NC
Olfaction-Gustation .86 [.69 ; 1.00] 7 77.8% 85.3% 84.3%
Psychosocial impact 
of changes in the 
physical appearance
.68 [.49 ; .88] NC NC NC NC
Neck and/or 
shoulder limitations
.70 [.57 ; .83] 7 70.8% 52.2% 58.6%
Psychosocial .48 [.21 ; .75] NC NC NC NC
Discussion
Acceptable psychometric properties:
Construct
validity
• 11-dimension 
structure 
validated
• Moderate
correlation
between
Swallowing and 
Feeding
• Impact of 
psychosocial 
dimension on 
other scores?
Clinical validity
• Pain and 
Vision: weak
Criterion
validity
• Good 
correlations 
between CHI 
scores and VAS
Internal
consistency
• High 
Cronbach’s
alphas > .72
Test-retest
reliability
• Good 
correlations 
between T0 
and T1 (r > .67): 
reproducible 
measure
Discussion
Clinical use:
Modular application
Threshold:
No threshold for 3 dimensions
Cautious interpretation
for 3 other dimensions
Acceptable performance 
(> 75%) for the other dimensions
CHI: valid and reliable tool
Dimension
AUC (Area Under 
the Curve)
Threshold
Chosen
threshold
Correct 
classification
Pain .73 [.58 ; .87] 7 71.4%
Swallowing .84 [.73 ; .94] 4 81.4%
Feeding .78 [.67 ; .89] 7 75.7%
Respiration .74 [.54 ; .94] 4 54.3%
Phonation .85 [.74 ; .95] 6 81.4%
Hearing .88 [.79 ; .96] 8 81.4%
Vision .55 [.35 ; .75] ND ND
Olfaction-Gustation .86 [.69 ; 1.00] 7 84.3%
Psychosocial impact 
of changes in the 
physical appearance
.68 [.49 ; .88] ND ND
Neck and/or 
shoulder limitations
.70 [.57 ; .83] 7 58.6%
Psychosocial .48 [.21 ; .75] ND ND
